Cite
Towards a commercial process for the manufacture of genetically modified T cells for therapy.
MLA
Kaiser, A. D., et al. “Towards a Commercial Process for the Manufacture of Genetically Modified T Cells for Therapy.” Cancer Gene Therapy, vol. 22, no. 2, Mar. 2015, pp. 72–78. EBSCOhost, https://doi.org/10.1038/cgt.2014.78.
APA
Kaiser, A. D., Assenmacher, M., Schröder, B., Meyer, M., Orentas, R., Bethke, U., & Dropulic, B. (2015). Towards a commercial process for the manufacture of genetically modified T cells for therapy. Cancer Gene Therapy, 22(2), 72–78. https://doi.org/10.1038/cgt.2014.78
Chicago
Kaiser, A D, M Assenmacher, B Schröder, M Meyer, R Orentas, U Bethke, and B Dropulic. 2015. “Towards a Commercial Process for the Manufacture of Genetically Modified T Cells for Therapy.” Cancer Gene Therapy 22 (2): 72–78. doi:10.1038/cgt.2014.78.